Baris Ugar Agar

Title: Baris Ugar Agar: Innovator in Renal Therapy

Introduction

Baris Ugar Agar is a notable inventor based in Chicago, IL, who has made significant contributions to the field of renal therapy. With a total of two patents to his name, Agar's work focuses on improving the treatment of patients undergoing hemodialysis.

Latest Patents

Agar's latest patents include innovative methods for predicting serum potassium and phosphorus concentrations in patients during hemodialysis. The first patent, titled "Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis," outlines a method for predicting serum potassium concentrations by measuring levels throughout a hemodialysis session. This method involves calculating an ultrafiltration rate based on the patient's pre- and post-dialytic body weight and estimating potassium mobilization clearance and pre-dialysis distribution volume. The second patent, "Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis," similarly focuses on serum phosphorus concentrations, utilizing a comparable approach to predict levels during treatment.

Career Highlights

Throughout his career, Agar has worked with prominent companies such as Baxter International Inc. and Baxter Healthcare SA. His experience in these organizations has allowed him to develop and refine his innovative approaches to renal therapy.

Collaborations

Agar has collaborated with notable colleagues, including Alp Akonur and John Kenneth Leypoldt, contributing to advancements in the field of renal treatment.

Conclusion

Baris Ugar Agar's contributions to renal therapy through his patents and collaborations highlight his commitment to improving patient care in hemodialysis. His innovative methods for predicting serum concentrations are paving the way for enhanced treatment options for patients with renal failure.